Evidence map›Paper›PMID 30846549›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Microenvironment tailors nTreg structure and function.

Valérie Schiavon, Sophie Duchez, Mylène Branchtein, Alexandre How-Kit, Charles Cassius, Antoine Daunay, Yimin Shen, Sylvie Dubanchet, Renaud Colisson, Valérie Vanneaux and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. IFNα induces CCR5 in CD4Communications medicine · 2024
    Article
  4. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. TIGITJournal of autoimmunity · 2020
    Article
  13. Article
  14. The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 3 countries.

Valérie SchiavonLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.ORCID 0000-0001-8466-774X
Sophie DuchezInstitut de Recherche Saint-Louis, UMR CNRS 7212, Hôpital Saint-Louis, 75010 Paris, France.
Mylène BranchteinInstitut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.ORCID 0000-0001-7244-5066
Alexandre How-KitLaboratory for Genomics, Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain, 75010 Paris, France.
Charles CassiusLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.ORCID 0000-0002-5087-4414
Antoine DaunayLaboratory for Genomics, Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain, 75010 Paris, France.
Yimin ShenLaboratory for Bioinformatics, Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain, 75010 Paris, France.
Sylvie DubanchetLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.
Renaud ColissonTechnical Support, eBioscience, an Affymetrix Company, 91941 Courtaboeuf, France.
Valérie VanneauxCell Therapy Unit and Clinical Investigation Center in Biotherapies (CBT501), AP-HP, Hôpital Saint-Louis, 75010 Paris, France.
Alain PruvostService de Pharmacologie et d'Immunoanalyse, Commissariat à L'énergie Atomique, INRA, Université Paris-Saclay, 91190 Gif-Sur-Yvette, France.ORCID 0000-0002-7781-7735
Camille RoucairolResearch Department, Neovacs, 75014 Paris, France.
Niclas SetterbladInstitut de Recherche Saint-Louis, UMR CNRS 7212, Hôpital Saint-Louis, 75010 Paris, France.
Jean-David BouazizLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.
Marie-Christophe BoissierPathophysiology, Targets and Therapy of Rheumatoid Arthritis, INSERM UMR1125, Université Paris 13, Sorbonne Paris Cité, 93000 Bobigny, France.
Luca SemeranoPathophysiology, Targets and Therapy of Rheumatoid Arthritis, INSERM UMR1125, Université Paris 13, Sorbonne Paris Cité, 93000 Bobigny, France.
Carlos GrauxUniversité Catholique de Louvain, Centre Hospitalo-Universitaire - Université Catholique de Louvain (CHU UCL) Namur, 5530 Yvoir, Belgium.
Armand BensussanLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.ORCID 0000-0002-0409-2497
Arsène BurnyMolecular Biology Department, Université of Liège, 4000 Liège, Belgium.
Robert GalloInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201 rgallo@ihv.umaryland.edu dzagury@free.fr.
Daniel ZaguryResearch Department, Neovacs, 75014 Paris, France; rgallo@ihv.umaryland.edu dzagury@free.fr.ORCID 0000-0002-0603-3634
Hélène Le BuanecLaboratory of Oncodermatology, Immunology, and Cutaneous Stem Cells, INSERM U976, 75010 Paris, France.
Inserm · FRFondation Jean Dausset-CEPH · FRCentre National de la Recherche Scientifique · FRNeovacs (France) · FRAssistance Publique – Hôpitaux de Paris · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUCLouvain · BEUniversité Libre de Bruxelles · BEUniversity of Liège · BEUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural regulatory T cells (nTregs) ensure the control of self-tolerance and are currently used in clinical trials to alleviate autoimmune diseases and graft-versus-host disease after hematopoietic stem cell transfer. Based on CD39/CD26 markers, blood nTreg analysis revealed the presence of five different cell subsets, each representing a distinct stage of maturation. Ex vivo added microenvironmental factors, including IL-2, TGFβ, and PGE2, direct the conversion from naive precursor to immature memory and finally from immature to mature memory cells, the latest being a no-return stage. Phenotypic and genetic characteristics of the subsets illustrate the structural parental maturation between subsets, which further correlates with the expression of regulatory factors. Regarding nTreg functional plasticity, both maturation stage and microenvironmental cytokines condition nTreg activities, which include blockade of autoreactive immune cells by cell-cell contact, Th17 and IL-10 Tr1-like activities, or activation of TCR-stimulating dendritic cell tolerization. Importantly, blood nTreg CD39/CD26 profile remained constant over a 2-y period in healthy persons but varied from person to person. Preliminary data on patients with autoimmune diseases or acute myelogenous leukemia illustrate the potential use of the nTreg CD39/CD26 profile as a blood biomarker to monitor chronic inflammatory diseases. Finally, we confirmed that naive conventional CD4 T cells, TCR-stimulated under a tolerogenic conditioned medium, could be ex vivo reprogrammed to FOXP3 lineage Tregs, and further found that these cells were exclusively committed to suppressive function under all microenvironmental contexts.

Indexed as

ApyraseAutoimmune DiseasesCD4-Positive T-LymphocytesCellular MicroenvironmentCytokinesDendritic CellsDinoprostoneDipeptidyl Peptidase 4Forkhead Transcription FactorsHumansInterleukin-10Interleukin-2Leukemia, MyeloidTh17 CellsT-Lymphocytes, RegulatoryTransforming Growth Factor betaApyraseCytokinesDinoprostoneDipeptidyl Peptidase 4DPP4 protein, humanENTPD1 protein, humanForkhead Transcription FactorsFOXP3 protein, humanIL10 protein, humanInterleukin-10Interleukin-2Transforming Growth Factor betaadenosine deaminase-binding CD26CD39 regulatory receptorFOXP3 regulatory transcriptmicroenvironmental cytokinesnTregs

Identifiers

PMID30846549
PMCPMC6442590
OpenAlexW2922491803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.